Slim 2
- Manufacturer
- Bionutrigen Co., Ltd.
- Effective date
- 2011-09-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:29:37
Label at a glance#
ProductSlim 2
Active ingredientCIANIDANOL
Label structure8 sections
Label contents#
Full prescribing information#
active ingredient: catechin
INACTIVE INGREDIENT SECTION
inactive ingredient: HCA, lemon flavor, xylitol, maltitol, glucosyl stevia
OTC - PURPOSE SECTION
- healthy fat levels
- healthy weight
- improve blood circulation
- healthy weight
- improve blood circulation
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
take 1~3 packet daily
WARNINGS SECTION
DOSAGE & ADMINISTRATION SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60314-1001-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c5f3-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60314-1001-1 | Slim 2 | 6 g in 1 PACKET | POWDER | 6 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60314-1001 | SLIM 2 (CIANIDANOL) POWDER [BIONUTRIGEN CO., LTD.] | 1 | Legacy NDC, 1 package rows | 20110922_1602be4e-8dc8-4c45-b0a3-e623a1300751.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CIANIDANOL | ACTIVE INGREDIENT | 8R1V1STN48 | 1 | |
| CIANIDANOL | ACTIVE MOIETY | 8R1V1STN48 | 1 | |
| GLUCOSYL STEVIOL | INACTIVE INGREDIENT | TKD5UC898Q | 1 | |
| HYDROXYCITRIC ACID | INACTIVE INGREDIENT | 8W94T9026R | 1 | |
| LEMON | INACTIVE INGREDIENT | 24RS0A988O | 1 | |
| MALTITOL | INACTIVE INGREDIENT | D65DG142WK | 1 | |
| XYLITOL | INACTIVE INGREDIENT | VCQ006KQ1E | 1 |
Products#
Every source-derived product name is available through these pages.
- Slim 2
- CIANIDANOL
- HYDROXYCITRIC ACID
- LEMON
- XYLITOL
- MALTITOL
- GLUCOSYL STEVIOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 60314-1001 | 60314-1001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CIANIDANOL | 8R1V1STN48 | ACTIB |
| HYDROXYCITRIC ACID | 8W94T9026R | IACT |
| LEMON | 24RS0A988O | IACT |
| XYLITOL | VCQ006KQ1E | IACT |
| MALTITOL | D65DG142WK | IACT |
| GLUCOSYL STEVIOL | TKD5UC898Q | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MALTITOL | MALTITOL | D65DG142WK | SUSPENSION / ORAL | 39600 mg/120ml | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | SOLUTION / ORAL | 9000 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | CAPSULE / ORAL | 155 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | POWDER, FOR SUSPENSION / ORAL | 4223 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SUSPENSION, EXTENDED RELEASE / ORAL | 9000 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET, EXTENDED RELEASE / ORAL | 2752 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | FILM, SOLUBLE / ORAL | 29 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | PASTE / ORAL | 180 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | FILM / SUBLINGUAL | 24 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SOLUTION / ORAL | 21600 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | GUM, CHEWING / BUCCAL | 11915 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | GUM, CHEWING / BUCCAL | 4932 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SUSPENSION / ORAL | 1500 mg | ||
| MALTITOL | MALTITOL | D65DG142WK | FILM, SOLUBLE / ORAL | 44 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | TABLET, ORALLY DISINTEGRATING / ORAL | 360 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e21b68b7-9644-4c60-ae03-5171422215b4 | 1602be4e-8dc8-4c45-b0a3-e623a1300751 | 2011-09-15 | Warnings | e21b68b7-9644-4c60-ae03-5171422215b4 1602be4e-8dc8-4c45-b0a3-e623a1300751 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
